U.S., June 14 -- ClinicalTrials.gov registry received information related to the study (NCT07020520) titled 'EvaluatioN of Optilume Drug-Coated Balloon for the Endoscopic Treatment of UREteric Strictures' on May 27.
Brief Summary: The main objective of this clinical investigation is to assess the safety and feasibility of the Optilume DCB for treatment of ureteric strictures.
Study Start Date: Sept. 30, 2025
Study Type: INTERVENTIONAL
Condition:
Ureteral Stricture
Intervention:
DEVICE: Optilume
Has pre-treatment (balloon dilation or ureterotomy) followed by paclitaxel-coated balloon (Optilume) treatment of the ureteric stricture.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Urotronic Inc.
Disclaimer: Curated by HT Syndication....